البحث | SocioMint

Atess Karahan أضاف وظيفة جديدة أخرى
2026-07-29 08:37:06 -

Neurofibromatosis Market Share Analysis and Industry Insights
"According to the latest report published by Data Bridge Market Research, the Neurofibromatosis Market The global neurofibromatosis market size was valued at USD 14.60 billion in 2024 and is expected to reach USD 36.66 billion by 2032, at a CAGR of 12.20% during the forecast period Neurofibromatosis Market report contains most-detailed market segmentation, systematic analysis of...

0 التعليقات 0 المشاركات 26 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Surbhi Verma أضاف وظيفة جديدة Health
2026-07-10 10:32:21 -

MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringWorks Therapeutics) approved for pediatric and adult NF1 patients with symptomatic, inoperable tumors — represent the fastest-growing indication segment in the MEK inhibitor market, with the...

0 التعليقات 0 المشاركات 190 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

SocioMint https://sociomint.com